HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers

ConditionDermatitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-17
SponsorCentre Hospitalier Universitaire de la Réunion

About this trial

Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.

Eligibility criteria

Qualifiers

Children aged 8 to 17 years

Understanding french

Have a clinical diagnosis of mild-to-severe AD with a SCORing Atopic Dermatitis (SCORAD)

Referred by their referring physician in the Reunionese therapeutic education program for AD provided within the atopy school of the Reunion University Hospital. - Oral consent of the child and of one of the legal representatives collected.

Disqualifiers

Children refusing to participate in the hypnosis session

Not having the possibility to listen to an audio file,

Already practicing self-hypnosis for their AD before inclusion,

Having a contraindication to hypnosis (psychiatric disorders, psychosis)

Trial design

Treatments tested in this trial

  • Hypnosis

Treatment groups

32 Participants
are divided into 2 treatment groups